The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Biocon Sells 9.96% Stake In Contract Research Firm Syngene Via Open Market
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing
Topics
Biocon | biocon stock | Stake sale
BENGALURU (Reuters) - Indian biopharma company Biocon sold a 9.96% stake in its unit and contract research firm Syngene International through open market sale, it said in an exchange filing on Wednesday.
With the sale, the total promoter stake of Biocon in Syngene stands at 54.6%, the exchange filing showed.
Biocon did not reveal the price at which the stake was sold.
Officials at Syngene and Biocon did not immediately respond to a Reuters query seeking the reason for the stake sale and the price at which the sale was executed.
Biocon was selling the stake in Syngene to fund the acquisition of Viatris Inc's biosimilars business that it announced last year, CNBC TV-18 reported on Tuesday.
The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said.
Biocon Biologics had in February 2022 said it would buy the U.S. drug maker's biosimilars business in a deal valued at $3.34 billion.
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing.
Biocon's shares closed up 2%, while those of Syngene added 0.74% on Wednesday.
(Reporting by Nallur Sethuraman in Bengaluru; Editing by Dhanya Ann Thoppil)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, February 01 2023. 19:33 IST
RECENT NEWS
JPMorgan's Berlin Moment: Chase Takes On Europe
There is something quietly symbolic about JPMorgan Chase choosing Berlin as its gateway into continental Europe. In a fo... Read more
What Strategy's Bitcoin Sale Really Tells Us
There is a moment in every bull run when the narrative starts to fray. Not with a crash, not with a scandal, but with so... Read more
Coutts Sets Scope On New Continent
Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more
From Cypherpunk To Citadel
How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more
ACB Securities: Building Scale, Trust & Innovation
ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more
War Risk Returns To Markets As VIX Surges
For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more